INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 442m ago
HOUSE PTR42m ago
SEC 13F42m ago
ROBINHOOD CHAIN42m ago
Public company

ANIXAnixa Biosciences Inc

CIK 0000715446

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells3 / 0
Max Insider Score34
Connections4with evidence

ANIX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
TH
Titterton Lewis H jrDirector
ANIXAnixa Biosciences Inc
Open-market purchase
BUY$24K
8,000 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Titterton Lewis H jrDirector · Oct 26, 2026
  • ← Insider ofevidence
    Kumar AmitDirector, Chief Executive Officer · Oct 22, 2026
  • ← Insider ofevidence
    Catelani MichaelPresident, COO, & CFO · Sep 30, 2026
34
KA
Kumar AmitDirector, Chief Executive Officer
ANIXAnixa Biosciences Inc
Open-market purchase
BUY
$22K
8,000 sh
Oct 22, 2026
Oct 22, 2026
traded Oct 22, 2026
+0d
SEC FORM 4

Evidence

33
CM
Catelani MichaelPresident, COO, & CFO
ANIXAnixa Biosciences Inc
Open-market purchase
BUY$16K
5,500 sh
Sep 30, 2026Sep 30, 2026
traded Sep 30, 2026
+0dSEC FORM 4

Evidence